lansoprazole
CHEBI:CHEBI_6375
Chemical Information
- Molecular Formula
- C16H14F3N3O2S
- Molecular Mass
- 369.36259
- Charge
- 0
- SMILES
- Cc1c(OCC(F)(F)F)ccnc1CS(=O)c1nc2ccccc2[nH]1
- InChI
- InChI=1S/C16H14F3N3O2S/c1-10-13(20-7-6-14(10)24-9-16(17,18)19)8-25(23)15-21-11-4-2-3-5-12(11)22-15/h2-7H,8-9H2,1H3,(H,21,22)
- InChIKey
- MJIHNNLFOKEZEW-UHFFFAOYSA-N
Alternative Names
- 2-({[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl}sulfinyl)-1H-benzimidazole
- AG 1749
- Bamalite
- lansoprazol
- lansoprazolum
- Lanzol
- Lanzopral
- Lanzul
- Limpidex
- Monolitum
- Ogastro
- Opiren
- Prevacid
Treatment Applications
-
necrotizing gastritisView Disease →
DOID:4037
-
granulomatous gastritisView Disease →
DOID:4038
Drug Classification
-
sulfoxideView Class →
CHEBI:22063
-
pyridinesView Class →
CHEBI:26421
-
benzimidazolesView Class →
CHEBI:22715
-
t265116
-
t265118
-
t265290
-
t265337
-
t265412
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- DRON_00010000
- 17128
- oboInOwl#hasDbXref
- Wikipedia:Lansoprazole
- core#notation
- CHEBI:6375
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 17128
- oboInOwl#hasDbXref
- Wikipedia:Lansoprazole
- oboInOwl#id
- CHEBI:6375
- generic_name
- Lansoprazole micronized
- brand_name
- Good Sense Lansoprazole
- brand_name_base
- Good Sense Lansoprazole
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_49200
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- BFO_0000053
- http://purl.obolibrary.org/obo/DRON_00020324
- product_ndc
- 52562-021
- dosage_form
- TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE
- product_type
- BULK INGREDIENT
- marketing_category
- BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
- labeler_name
- Azurity Pharmaceutcials, Inc.
- application_number
- ANDA210465
- package_description
- 12 POUCH in 1 CASE (55111-739-48) / 4000 CAPSULE, DELAYED RELEASE in 1 POUCH (55111-739-94)
- package_ndc
- 65841-770-01
- spl_id
- 286ac402-ec14-4285-a56c-06ae757d37f9
- route
- ORAL
- rxcui
- 866152
- unii
- 0K5C5T2QPG
- spl_set_id
- cc006372-32d3-4539-921a-6bc9ec496b28
- manufacturer_name
- Macleods Pharmaceuticals Limited
- marketing_start_date
- 20180308
- package_marketing_start_date
- 14-JUL-16
- active_ingredient_strength
- 30 kg/30kg
- nui
- N0000009724
- active_ingredient_name
- LANSOPRAZOLE
- upc
- 0382009039053
- listing_expiration_date
- 20241231
- has_treatment
- http://purl.obolibrary.org/obo/DOID_9206
- rdf-schema#range
- https://w3id.org/def/predibionto#has_drug_113384
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect30873
- owl#annotatedSource
- t266418
- owl#someValuesFrom
- t3010839
- core#notation
- CHEBI:6375
- pharm_class_epc
- Proton Pump Inhibitor [EPC]
- pharm_class
- Inhibition Gastric Acid Secretion [PE]
- pharm_class_moa
- Proton Pump Inhibitors [MoA]
- pharm_class_pe
- Inhibition Gastric Acid Secretion [PE]
- brand_name_suffix
- 24 HR
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class